Seneca Growth Capital VCT PLC (HYG) - Total Assets
Based on the latest financial reports, Seneca Growth Capital VCT PLC (HYG) holds total assets worth GBX14.16 Million GBX (≈ $1.72K USD) as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Seneca Growth Capital VCT PLC (HYG) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Seneca Growth Capital VCT PLC - Total Assets Trend (2001–2024)
This chart illustrates how Seneca Growth Capital VCT PLC's total assets have evolved over time, based on quarterly financial data. Explore investment intensity of Seneca Growth Capital VCT PLC to see how much of total assets are deployed in long-term investments.
Seneca Growth Capital VCT PLC - Asset Composition Analysis
Current Asset Composition (December 2024)
Seneca Growth Capital VCT PLC's total assets of GBX14.16 Million consist of 10.9% current assets and 89.1% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 10.9% |
| Accounts Receivable | GBX11.00K | 0.1% |
| Inventory | GBX0.00 | 0.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2001–2024)
This chart illustrates how Seneca Growth Capital VCT PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see HYG market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Seneca Growth Capital VCT PLC's current assets represent 10.9% of total assets in 2024, an increase from 0.0% in 2001.
- Cash Position: Cash and equivalents constituted 10.9% of total assets in 2024, up from 0.0% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 0.1% of total assets.
Seneca Growth Capital VCT PLC Competitors by Total Assets
Key competitors of Seneca Growth Capital VCT PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Metrics Master Income Trust
AU:MXT
|
Australia | AU$2.46 Billion |
|
Jpmorgan Global Core Real Assets Ltd
LSE:JARA
|
UK | GBX70.85 Million |
|
Northern Trust Corporation
NASDAQ:NTRS
|
USA | $174.57 Billion |
|
Principal Financial Group Inc
NASDAQ:PFG
|
USA | $332.70 Billion |
|
Industrivarden AB ser. C
ST:INDU-C
|
Sweden | Skr211.38 Billion |
|
Sprott Physical Gold and Silver Trust
TO:CEF
|
Canada | CA$9.34 Billion |
|
Anxin Trust Co Ltd
SHG:600816
|
China | CN¥26.40 Billion |
|
Norte Grande
SN:NORTEGRAN
|
Chile | CL$2.96 Billion |
Seneca Growth Capital VCT PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.55 | 7.70 | 16.58 |
| Quick Ratio | 9.55 | 7.77 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX1.38 Million | GBX1.27 Million | GBX3.68 Million |
Seneca Growth Capital VCT PLC - Advanced Valuation Insights
This section examines the relationship between Seneca Growth Capital VCT PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.13 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -17.8% |
| Total Assets | GBX14.16 Million |
| Market Capitalization | $8.89K USD |
Valuation Analysis
Below Book Valuation: The market values Seneca Growth Capital VCT PLC's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Seneca Growth Capital VCT PLC's assets decreased by 17.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Seneca Growth Capital VCT PLC (2001–2024)
The table below shows the annual total assets of Seneca Growth Capital VCT PLC from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX14.16 Million ≈ $1.72K |
-17.82% |
| 2023-12-31 | GBX17.23 Million ≈ $2.10K |
-7.63% |
| 2022-12-31 | GBX18.65 Million ≈ $2.27K |
+2.04% |
| 2021-12-31 | GBX18.28 Million ≈ $2.22K |
+63.41% |
| 2020-12-31 | GBX11.19 Million ≈ $1.36K |
+28.97% |
| 2019-12-31 | GBX8.67 Million ≈ $1.06K |
-11.16% |
| 2018-12-31 | GBX9.76 Million ≈ $1.19K |
+75.23% |
| 2017-12-31 | GBX5.57 Million ≈ $677.83 |
-7.80% |
| 2016-12-31 | GBX6.04 Million ≈ $735.14 |
-8.32% |
| 2015-12-31 | GBX6.59 Million ≈ $801.81 |
-18.60% |
| 2014-12-31 | GBX8.10 Million ≈ $985.05 |
-7.03% |
| 2013-12-31 | GBX8.71 Million ≈ $1.06K |
-19.59% |
| 2012-12-31 | GBX10.83 Million ≈ $1.32K |
+87.91% |
| 2011-12-31 | GBX5.76 Million ≈ $701.19 |
-8.70% |
| 2010-12-31 | GBX6.31 Million ≈ $767.99 |
-14.98% |
| 2009-12-31 | GBX7.42 Million ≈ $903.29 |
+42.19% |
| 2008-12-31 | GBX5.22 Million ≈ $635.24 |
+12.69% |
| 2007-12-31 | GBX4.63 Million ≈ $563.70 |
+7.07% |
| 2006-12-31 | GBX4.33 Million ≈ $526.47 |
-25.52% |
| 2005-12-31 | GBX5.81 Million ≈ $706.91 |
-8.29% |
| 2004-12-31 | GBX6.33 Million ≈ $770.79 |
-10.50% |
| 2003-12-31 | GBX7.08 Million ≈ $861.19 |
+3.89% |
| 2002-12-31 | GBX6.81 Million ≈ $828.95 |
+13526.00% |
| 2001-12-31 | GBX50.00K ≈ $6.08 |
-- |
About Seneca Growth Capital VCT PLC
Seneca Growth Capital VCT plc is a venture capital trust specializes in growth capital. It invests in emerging biotechnology companies. It prefers to invest in unquoted and quoted MedTech companies. The fund seeks to invest in the United Kingdom, IIe-de-France, Burgundy, France, European Developed Markets. It typically invests in companies with sales greater than £10 million ($11.90 million), gro… Read more